Oxygen-15 positron-emission tomography for predicting selective delivery of a chemotherapeutic agent to hepatic cancers during angiotensin II-induced hypertension

Cancer Chemotherapy and Pharmacology

Volumn 51, Issue 4, 2003, Pages 349-358

  Koh, Toshimori ^a   Taniguchi, Hiroki ^b   Yamagishi, Hisakazu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Angiotensin II; Hepatocellular carcinoma; Hypertension chemotherapy; Metastatic liver cancer; Positron emission tomography

Indexed keywords

ANGIOTENSIN; ANTINEOPLASTIC AGENT; OXYGEN 15;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; DRUG DELIVERY SYSTEM; FEMALE; HEPATIC ARTERY; HUMAN; HYPERTENSION; LIVER BLOOD FLOW; LIVER CANCER; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER PARENCHYMA; LIVER TUMOR; MALE; PORTAL VEIN BLOOD FLOW; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; SPLEEN; SPLEEN BLOOD FLOW; STEADY STATE; TUMOR BLOOD FLOW;

EID: 0038578338     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-003-0575-2     Document Type: Article

References (23)

1. Flower MA, Zweit J, Hall AD, Burke D, Davies MM, Dworkin MJ, Young HE, Mundy J, Ott RJ, McCready VR, Carnochan P, Allen-Mersh TG (2001) 62Cu-PTSM and PET used for the assessment of angiotensin II-induced blood flow changes in patients with colorectal liver metastases. Eur J Nucl Med 28:99
2. Goldberg JA, Kerr DJ, Wilmott N, McKillop JH, McArdle CS (1990) Regional chemotherapy for colorectal liver metastases: a phase II evaluation of targeted hepatic arterial 5-fluorouracil for colorectal liver metastases. Br J Surg 77:1238
3. Hemingway DM, Chang D, Cooke TG, Jenkins SA (1991) The effects of vasopressin infusion on hepatic haemodynamics in an experimental model of liver metastases. Br J Cancer 64:212
4. Hori K, Suzuki M, Tanda S, Saito S, Shinozaki M, Zhang QH (1991) Fluctuations in tumor blood flow under normotension and the effect of angiotensin II-induced hypertension. Jpn J Cancer Res 82:1309
5. Hoshi M, Sato H (1995) Angiotensin II-induced hypertension chemotherapy (IHC) for advanced gastrointestinal, pancreatic and hepatobiliary carcinoma. Intern Med 34:298
6. Kemeny N, Yagoda A, Braun D Jr, Golbey R (1980) Therapy for metastatic colorectal carcinoma with a combination of methyl-CCNU, 5-fluorouracil vincristine and streptozotocin (MOF-Strep). Cancer 45:876
7. Leung TW, Johnson PJ (2001) Systemic therapy for hepatocellular carcinoma. Semin Oncol 28:514
8. Nelder JA, Mead R (1965) A simplex method for function minimization. Computer J 17:443
9. Onohara S, Kobayashi H, Itoh Y, Shinohara S (1988) Intraarterial cis-platinum infusion with sodium thiosulfate protection and angiotensin II induced hypertension for treatment of hepatocellular carcinoma. Acta Radiol 29:197
10. Sasaki Y, Imaoka S, Hasegawa Y, Nakano S, Ishikawa O, Ohigashi H, Taniguchi K, Koyama H, Iwanaga T, Terasawa T (1985) Changes in distribution of hepatic blood flow induced by intra-arterial infusion of angiotensin II in human hepatic cancer. Cancer 55:311
11. Schoning M, Scheel P (1996) Color duplex measurement of cerebral blood flow volume: intra- and interobserver reproducibility and habituation to serial measurement in normal subjects. J Cereb Blood Flow Metab 16:523
12. Sitzmann JV, Wu Y, Aguilera G, Cahill PA, Burns RC (1995) Loss of angiotensin-II receptors in portal hypertensive rabbits. Hepatology 22:559
13. Suzuki M, Hori K, Abe I, Saito S, Sato H (1981) A new approach to cancer chemotherapy: selective enhancement of tumor blood flow with angiotensin II. J Natl Cancer Inst 67:663
14. 15O. Ann Nucl Med 7:141
15. Taniguchi H, Oguro A, Koyama H, Miyata K, Takeuchi K, Takahashi T (1995) Determination of the spleen-blood partition coefficient for water with oxygen-15-water and oxygen-15-carbon dioxide dynamic PET steady-state methods. J Nucl Med 36:599
16. Taniguchi H, Koyama H, Masuyama M, Takada A, Mugitani T, Tanaka H, Hoshima M, Takahashi T (1996) Angiotensin-II-induced hypertension chemotherapy: evaluation of hepatic blood flow with oxygen-15 PET. J Nucl Med 37:1522
17. Taniguchi H, Oguro A, Koyama H, Masuyama M, Takahashi T (1996) Analysis of models for quantification of arterial and portal blood flows in the human liver using positron emission tomography. J Comput Assist Tomogr 20:135
18. Taniguchi H, Yamaguchi A, Kunishima S, Koh T, Masuyama M, Koyama H, Oguro A, Yamagishi H (1999) Using the spleen for time-delay correction of the input function in measuring hepatic blood flow with oxygen-15 water by dynamic PET. Ann Nucl Med 13:215
19. 15O] water and positron emission tomography. Nucl Med Commun 22:755
20. 15O] water and positron emission tomography. Nucl Med Commun (in press)
21. Tomura N, Kato T, Kanno I, Shishido F, Inugami A, Uemura K, Higano S, Fujita H, Mineura K, Kowada M (1993) Increased blood flow in human brain tumor after administration of angiotensin II: demonstration by PET. Comput Med imaging Graph 17:443
22. Wakui A, Sato H (1984) Clinical studies on induced hypertension chemotherapy based on functional characteristics of microcirculation of tumor vessels (in Japanese). Jpn J Cancer Chemother 11:741
23. Wu YP, Li SS, Campbell KA, Sitzmann JV (1991) Modulation of splanchnic vascular sensitivity to angiotensin II. Surgery 110:162